# Amneal Pharmaceuticals, Inc. (AMRX): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Amneal Pharmaceuticals, Inc. (AMRX) is 86/100, ranked against 24,000+ stocks in 35 markets (Quality 65, Value 31, Momentum 90, each scored against its sector).

- StockRank: 86/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 65, Value 31, Momentum 90: each a 0-100 percentile within Healthcare.
- Position: #3,595 overall, #401 in Healthcare.
- Listing: United States, NMS; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 21.02 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 7.7M.

Source: https://moatmap.ai/stock/AMRX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker